Navigation Links
Halozyme Reports First Quarter 2012 Financial Results
Date:5/7/2012

statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected expenditures, clinical trial results, delays in development and regulatory review, regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
aerickson@halozyme.com Halozyme Therapeutics, Inc.Unaudited Condensed Consolidated Statements of OperationsThree Months Ended March 31,20122011REVENUES:Product sales, net

$
87,411$165,449Revenues under collaborative agreements

7,252,7687,378,445Total revenues

7,440,1797,543,894OPERATING EXPENSES:Cost of product sales

70,76111,717Research and development

15,891,10913,785,797Selling, general and administrative

6,618,7073,405,966Total operating expenses

22,580,57717,203,480OPERATING LOSS

(15,140,398)(9,659,586)Interest and other income, net

21,21723,869NET LOSS

$  (15,119,181)$ (9,635,717)Basic and diluted net loss per share

$
(0.14)$
(0.10)Shares used in computing basic and diluted net loss per share

107,589,514100,927,402 Halozyme Therapeutics, Inc.Unaudited Condensed Consolidated Balance SheetsMarch 31,December 31,20122011ASSETSCurrent assets:Cash and cash equivalents

$
,608,304$
52,825,527Account
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme to Host First Quarter 2012 Financial Results Conference Call
2. ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20)
3. Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
4. Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock
5. Halozyme Announces Proposed Public Offering of Common Stock
6. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
7. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
8. Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting
9. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
10. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
11. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015 About Pressure Relief ... area and improve the quality life of patients who ... play a significant role in inhibiting the growth and ... to turn or rotate an immobile patient by providing ... overlay, and specialty beds. These devices have the ability ...
(Date:6/1/2015)... -- The Middle Eastern MRI systems market is fast growing. ... all domains of medicine like cardiology, neurology and orthopedics. It ... precision and is as safer tool as it does not ... on equipment into Open system, closed system and straight or ... demand as it is preferred over that currently common closed ...
(Date:6/1/2015)...  Diomics, an innovator in DNA capture technology, today ... executive, has joined Diomics, board of directors, effective immediately. ... of industry experience in broad global financial investment banking. ... at Credit Suisse and JP Morgan, and held executive ... "Diomics is on the forefront of innovation," said Mr. ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3Richard M. Weissman joins Diomics Board of Directors 2
... College of Emergency Physicians, a national sponsor of the ... safe disposal of expired, unused and unwanted medications in ... accidental overdose.  A recent study reports that prescription drugs ... 2008, more than half of the total 36,450 overdose ...
... The U.S. Food and Drug Administration today approved the ... heart valve damaged by senile aortic valve stenosis without ... Senile aortic valve stenosis is a progressive, age-related disease ... cause the valve to narrow. As the heart works ...
Cached Medicine Technology:Emergency Physicians Tell the Public,''Get Rid of Your Stash'' of Unwanted Meds on November 12th 2FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery 2FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery 3
(Date:6/1/2015)... The National Association of Professional ... a 2015-2016 inductee into its VIP Woman of the ... for leadership in business. NAPW is the nation’s leading ... 700,000 members and over 200 operating Local Chapters. , ... said NAPW President Star Jones. “Job satisfaction is essential ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Linda Cade as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... exclusively for professional women, boasting more than 700,000 members ... to recognize Linda with this important honor,” said NAPW ...
(Date:6/1/2015)... June 01, 2015 Carson Energy also ... their investors IRA transactions. AdvantaIRA Trust, LLC is the ... the ability to fund positions using IRA’s does 2 ... on a project, even if there current cash position ... additional funding source for Carson and their investors to ...
(Date:6/1/2015)... The Delta Dental Foundation is currently seeking ... Michigan, Ohio and Indiana for its Brighter Futures Community ... has been set. , Across the tri-state area, the ... specifically focus on children’s oral health and $100,000 in ... adults. Each grant request will be considered and carefully ...
(Date:6/1/2015)... 01, 2015 EBSCO Health , ... introduced DynaMed Plus™ , a cross-platform evidence-based clinical ... It provides clinicians with the ideal blend of evidence ... paths. , DynaMed Plus is a significant enhancement ... the most frequently updated evidence-based content. DynaMed Plus content ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4
... University of California, San Diego, have identified a key ... in humans and mice. This groundbreaking discovery has implications ... of patients with pulmonary arterial hypertension and prevent the ... this debilitating disease. In a paper to be ...
... today,s Scientific Program of the 2009 American Academy of ... Meeting include: John T. Flynn, MD, Columbia University School ... in caring for the vision of the tiniest premature ... Stanford University School of Medicine, on barriers to glaucoma ...
... ... Advantage has developed a proprietary web application named “iCompli®” designed to ... their physician protocols. The application is designed to notify the ... their mobile phone. iCompli® will work with any mobile device or ...
... patients have best chance at some visual recovery, research suggests ... improve the vision of people with a severe form of ... new study shows. , People with LCA, which is caused ... vision loss and abnormal eye movements in early infancy and ...
... ... Debate , ... (Vocus) October 22, 2009 -- According to the Centers for Disease Control and Prevention, the ... country. They also report that hospitalizations of related cases have been above average for this ...
... "Physician ... of EMR Adoption , , ... Doylestown, PA (PRWEB) October 23, 2009 -- myemrchoice.com announced that they will ... Doctors EMR Quarterly and the EMR Power Ranking. The new EMR planning resources ...
Cached Medicine News:Health News:UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 2Health News:Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic 2Health News:Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic 3Health News:Bariatric Advantage Launches First of Its Kind Mobile Vitamin Reminder Web Application 2Health News:Gene Therapy Offers Hope for Severe Hereditary Eye Disease 2Health News:Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 2Health News:Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 3Health News:MyEMRchoice.com develops EMR Power Rankings for Selection of Electronic Medical Records 2
... a basic Peripheral Nerve Locator only, which ... location during regional anesthesia. Ideal for day ... constant current NS232, NS252, NS272 PNS are ... programmed. ,Hand-held, battery operated, and includes automatically ...
Pocket-size digital nerve locator optimizes ease and convenience of performing peripheral nerve blocks. Includes RBW-5L electrode lead set, 9V alkaline battery, and durable molded polyethylene carryi...
Single cuff electronic tourniquet....
The Lone Star Retractor System may be adapted to a specific region of the anatomy by simply adjusting the hinges. The system also includes multiple ring shapes, slots on perifephery of retractor ring...
Medicine Products: